Stay updated with breaking news from Altavant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases,...
/PRNewswire/ -- Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases,...
/PRNewswire/ -- The "Global Respiratory Partnering 2010-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering....
/PRNewswire/ -- The "Global Respiratory Partnering 2010-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering....
Currently, major driving factors for Bronchiolitis Obliterans Syndrome market include development of potential therapies such as Zambon's Phase III asset, Liposomal cyclosporine A, under clinical